Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    COVID plus MI confers poor prognosis; 1 in 3 die in hospital

    April 22, 2021

    National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.

  • 1
    News

    Assessing the efficacy and safety of dapagliflozin in patients with HFrEF

    April 22, 2021

    Can the use of dapagliflozin, in addition to guideline-directed medical therapy, improve patient-reported outcomes and health-related quality of life in patients with heart failure and reduced ejection fraction (HFrEF)?

  • 1
    News

    Pneumonia risk soars in heart failure patients, especially HFpEF

    April 19, 2021

    An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular events.

  • 1
    News

    How often should we check EKGs in patients starting antipsychotic medications?

    April 19, 2021

    A prolonged QT interval can predispose a patient to dangerous arrhythmias that can result in sudden cardiac death.

  • News

    How some COVID-19 vaccines could cause rare blood clots

    April 14, 2021

    Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.

  • 1
    News

    Arthritis drug may curb myocardial damage in acute STEMI

    April 13, 2021

    Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.

  • News

    More evidence MIS-C is a delayed response to SARS-CoV-2

    April 13, 2021

    CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”

  • News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.

  • 1
    News

    Longitudinal associations between income changes and incident CVD

    April 2, 2021

    Is there an association between income change and cardiovascular disease (CVD)?

  • News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

Previous1 … 15 16 17 18 19 … 80Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences